Actually, RCB, it was strictly about valve-related disease. Don't forget, some people have multiple valve problems, but the secondary valve issue may not be close to bad enough to do anything with at surgical time. Ten or twenty years later, it may well have progressed. Or they may have tissue problems that progress with time, regardless of the valve. It would probably be a similar number with any valve.
The bleeding incident demarkation is determined by those who do the study. Mr. Lodwick, while deserving, doesn't get a say in their study parameters.
The numbers are not, I am sure, as sweet as we'd like. But they are about as good as valve replacement numbers can be expected to be over time. It is doubtful that any other valve would have a significantly better set of stats, mechanical or tissue. Maybe the On-X will have a slight edge in twenty years. Or the CEPM. Or neither.
What everyone really wants to read from a study is, "We implanted 2,176 (insert brand/type here) valves between February 17th and October 12, 1980, and studied the patients for twenty five years. Everyone is fine." But that study isn't going to happen for any valve.
The odds are excellent for valvers, better than they have ever been before. I believe it would be reassuring if we had a listing of how many of the demised or rediseased valvers in the study had already passed their threescore and sixteen. (Maybe not so thilling for our more senior members, of course. I'm counting on their philosophical natures in pointing this out.)
The numbers need to be taken in a larger context. A conk on the head at 20 leaves a lump. At 82, it may open an aneurism in the brain. Ergo: bleeding event. Because of the average age of the patients, the time-in-life factor will always torque the numbers in valve studies to some extent.
Be happy,